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ABSTRACT 
Weak Rh D phenotypes are very frequent in Africans. They are capable of causing alloimmuniza-
tion in Rh D-negative individuals. Some weak Ds may elude routine typing using direct agglutina-
tion techniques. This study aimed at determining the prevalence of weak D phenotype among Rh-
negatives, using indirect antiglobulin technique. A total of 400 donors between the ages of 16 and 
35 years who were grouped by the blood bank were randomly sampled over a period of 2 months. 
Three hundred and sixty nine (92.25%) were typed as Rh D-positive and 31 (7.75%) RhD-negative. 
Two (6.45%) of the Rh D-negative donors were weak D positive while 29 (93.55%) were weak D 
negative. Among the males 25 (9.43%) were Rh D-negative and 240 (90.57%) RhD-positive. Two 
(8%) of the 25 males were weak D positive. Among the females, 6 (4.44%) were Rh D-negative and 
129 (95.56%) RhD- positive. This implies that, there are people in Kumasi with weak D phenotype 
which cannot be detected by the direct monoclonal anti-D agglutination. Consequently, indirect 
antiglobulin test may be indicated for such individuals typed Rh D-negative. This study has shown 
the need for a comprehensive policy on appropriate testing of donors and newborns, and manage-
ment of Rh D-negative mothers in the Region. This should include weak D testing of all Rh D-
negative blood donors before transfusion in Rh D-negative patient.  
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INTRODUCTION 
The Rh blood-group system is clinically impor-
tant because antibodies against Rh antigens are 
involved in haemolytic disease of the newborn, 
haemolytic transfusion reactions, and autoim-
mune haemolytic anaemia (Issitt, 1989; Issitt and 
Telen, 1996). Individuals are classified as Rh-
positive and Rh-negative according to the pres-
ence or absence of the D antigen on the surface 
of their red cells (Issitt, 1989), which is the most 
immunogenic, and therefore, of critical impor-
tance for the blood transfusion strategy, and 
proper management of Rh-negative gravid 
women. 
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The RhD blood group antigen has been shown to 
be subject to many phenotypic variations (Jones 
et al., 1995; Jones et al., 1996) and the fre-
quency of weak D phenotype varies with the 
method used, the reagent used, and the racial 
mix tested (Division of Medical Laboratory Sci-
ence, 2001). The incidence of weak D phenotype 
is high among blacks. The frequency of the 
weak D phenotype in whites is approximately 
0.2% to 1% (Flegel et al., 2000; Wagner et al., 
2000), up to 10% in Africans (Cheesbrough, 
2000), 7.5% among the Yoruba of South-
Western Nigeria, 0.75% in Kenya (Lyko et al., 
1992), 0.6% in the United Kingdom (Nwauche 
et al., 2003) and approximately 0.23% in USA 
(Mollison et al., 1997). Nwauche et al., (2003) 
found 0.95% among adult females in Port Har-
court, Nigeria. These varied results from Nigeria 
depicted heterogeneity in the prevalence of weak 
D, even among somewhat homogenous entities. 
Weak D phenotypic expression is known to arise 
from three mechanisms (Tippett, 1988). In one 
of these mechanisms, referred to as gene interac-
tion, there is a suppressive effect of the C gene 
when in trans to the D gene (e.g., Dce/Ce). The 
second is when part of the D antigen is missing 
(partial D). Thirdly, the presence of an aberrant 
form of D (e.g., at the molecular level) would 
result in weak phenotypic expression. The term 
‘Weak D’ actually refers to red cells with the 
aberrant RhD protein, expressing reduced mem-
brane surface D antigens. The partial Ds, some-
times give weak phenotypic reactions in sero-
logic procedures. Because serologic distinction 
is currently not possible, many laboratories 
would detect some partial D’s as weak D. It is 
known that many partial D phenotypes present 
as normal D types (e.g. react strongly with rou-
tine anti-D) so they are often not classified until 
they make anti-D. 
The number of D antigen sites on the Rh D-
positive red blood cells is normally in the range 
of 9900 to 33000 (Issitt and  Telen, 1996) and 
the weak D phenotype appeared to be a quantita-
tive variation in the number of D antigen sites on 
the red blood cell (Mollison et al., 1997). Pri-
marily, the weak D is the result of point muta-
tions that cause amino acid changes predicted to 
be intracellular or in the transmembrane regions 
of RhD and not on the outer surface of the RBC 
(Wagner et al., 1999). These mutations, they 
indicated, affect the efficiency of insertion, and 
therefore, the quantity of RhD protein in the 
membrane. The inefficient insertion, reflected in 
the reduced number of antigen sites on these red 
blood cells, and explains why the indirect an-
tiglobulin test (IAT) may be required for detec-
tion (Wagner et al., 1999). It was confirmed 
latter that, most weak D types, including preva-
lent ones, carry altered D antigens (Wagner et 
al., 2000). 
In the laboratory, serologic typing techniques 
employing the use of anti-D sera are mainly used 
to detect the presence of the Rh D antigens on 
the red blood cells of individuals. The number of 
samples classified as weak D depends on the 
characteristics of the typing reagent (Westhoff, 
2004). Weak D individuals (who are actually Rh
-positive) were commonly mistyped as Rh-
negative through the use of polyclonal antibod-
i s with grave consequences (Calhun and  Petz, 
1995). However, with the advent of monoclonal 
anti-D reagents, most weak D individuals are 
now typed as Rh-positive. It is now becoming 
evident that there are some immunogenic weak 
D samples that would not be detected by direct 
agglutination. Antihuman globulin test may 
therefore need to be performed to detect weak D 
red cells in individuals who initially type as Rh-
egative.  The objective of this study therefore, 
is to determine the prevalence of weak D (Du) 
phenotype among Rh-negative males and fe-
males in Kumasi. 
 
MATERIALS AND METHODS  
Materials used 
Blood bags containing anticoagulant Citrate 
Phosphate Dextrose Adenine solution, CPDA-1 
(USP), AGARY® blood bag (Agary Pharmaceu-
tical Ltd, Shandong, China) was used; RhD and 
ABO typing was done using kits from DiaMed-
ID Micro Typing Technique (Lorne Laboratory 
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Ltd-Great Britain); Weak D. (Du) was typed 
using indirect anti-globulin technique (Biotech 
Laboratory Limited, UK) and HbsAg, HCV, 
HIV were determined using new rapid point-of-
care tests, the DetermineTM series (Abbott, Ab-
bott Park, IL). 
 
Donor Selection (Inclusion/Exclusion Criteria) 
Donors were selected whose blood pressure 
were between 90-140/60-90 mmHg and body 
weight of 50kg and above. They were also 
screened for HbsAg, HCV, and HIV-antibodies 
and must have tested negative. Their Hb values 
were also12g/dl (for females) or 13g/dl (for 
males). 
Those excluded from donating blood fell within 
the following categories: 
• Taking drugs for high blood pressure or 
heart failure 
• Having Hb below 12g/dl (for females) or 
13g/dl (for males) 
• Tested positive for HbsAg, HCV, and HIV
-antibodies. 
• Have had jaundice, liver disease, epilepsy, 
diabetes, duodenal or gastric ulcer, asth-
matic and tuberculosis 
• Drug addict, or  taken self injected drugs 
• Sickle Cell Disease e.g.: SS, SC, Sβ-thal 
• Prostitute and/or homosexual 
• Experienced severe weight loss within the 
last six months. 
 
Subjects and sample preparation  
This study included 400 adult men and women 
with an age range 16 to 35 years who had been 
grouped by the blood bank. They include 265 
males and 135 females voluntary blood donors 
living in Kumasi. The blood donors were those 
routinely bled by the staff of blood bank unit of 
Komfo Anokye Teaching Hospital, Kumasi. 
The blood was collected into blood bags con-
taining Citrate Phosphate Dextrose Adenine 
and mixed. After the donation exercise, the 
units of blood were grouped for ABO and Rh 
status and kept in the blood bank at between 4-
6oc. This study had the approval of the Man-
agement of the Transfusion Medicine Unit to use 
the donor blood already grouped. Three ml of 
the banked blood was collected into plain test 
tubes and re-tested for ABO and RhD typing 
using the DiaMed-ID Micro Typing Technique 
(Lorne Laboratory Ltd-Great Britain). Weak D 
(Du) was typed using indirect anti-globulin tech-
nique (Biotech Laboratory Limited, UK) on all 
Rh-negative subjects. The results were recorded: 
(+) for agglutination and (-) for no agglutination. 
A known donor of blood group ‘O’ Rh D posi-
tive was used as a positive control; another 
known donor of ‘O’ Rh D negative was used as 
a negative control. 
 
RESULTS  
Figure 1A shows the frequency of RhD-negative 
and RhD-positive among blood donors. Of the 
subjects 92.25% (369/400) were RhD-positive 
and 31 (7.75%) RhD-negative. Among the fe-
males, 4.44% (6/135) of them were RhD-
negative with 95.56% (129/135) being RhD-
positive (Figure 1B). Of the males, 9.43% 
(25/265) were RhD-negative and 90.57% were 
RhD-positive (Figure 1C). 
Out of the 31 Rh-negative subjects, 25, repre-
senting 6.25% of the 400 were males whilst 6 
(1.50%) were female (Table 1). Table 2 shows 
the prevalence of weak D phenotype among the 
Rh-negative males and females. Out of the 31 
apparently negative subjects, 6.45% (2/31) were 
detected to be weak D positive with the other 
93.55% being negative (Figure 1D). Both sam-
ples were from males, thus 8% (2/25) of the Rh-
egative males were weak D-positive. No weak 
D was detected in the 6 Rh-negative females. 
DISCUSSION 
The finding of 7.75% prevalence of Rh-negative 
among donors in this study (Fig 1A) is in keep-
ing with available records of low prevalence of 
Rh-negative in other African countries. Among 
Kenyans 3.9% has been reported and 1-6% 
among Nigerians (Nwauche t al., 2003). The 
low incidence of Rh-negativity contrasts mark-
edly with high figures obtained elsewhere, for 
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example, about 15% - 17% among Europeans 
(Race and  Sanger, 1975) and 15% in the USA 
population (Mollison et al., 1997). This could be 
due the high RHD gene frequency among Afri-
cans (Flegel and  Wagner, 2002), and for that 
matter, Ghana. 
Weak D prevalence among Africans has been 
said to be as high as up to about 10% 
(Cheesbrough, 2000). Consistent with this, is the 
finding of a 6.45% weak D prevalence among 
the subjects involved in this study (Fig 1D). This 
is however, a little below the 7.5% prevalence 
reported among the Yoruba of South-Western 
Nigeria (Nwauche et al., 2003). On the other 
hand, the 6.45% is high, compared to those 
found in some other populations; for instance, 
approximately 0.4% among the Caucasians 
(Flegel et al., 2000). The relatively small num-
ber of Rh-negative samples obtained could ac-
count for the high weak D prevalence obtained 
in this investigation. However, it should be 
noted that RhD frequency depends on ethnicity. 
In Africans, the frequency of aberrant RHD al-
leles, which encode weak D is much higher 
(Flegel and  Wagner, 2002). This could also 
account for the high weak D prevalence obtained 
in this study. 
Though the two weak D donors were men, it 
may not be suggestive that weak D is more 
prevalent among males than females. It should 
be noted there were only 6 Rh-negatives out of 
135 females. This should compare with our find-
ing that 25 of the 265 males were Rh-negative. 
Considering the fact that monoclonal anti-D 
antisera, were used in the direct agglutination 
test it is obvious that the two samples that 
showed weak D phenotypic reactions had low 
antigen D density.  This attests to previous ob-
servation that donors who are carriers of some 
weak D may pass unnoticed in tests based on 
direct agglutination with monoclonal anti-D 
(Wagner et al., 2001). The results of this study, 
however, questions the opinion that there is no 
need to test Rh negative samples for weak D 
when using monoclonal IgM anti D 
(Cheesbrough, 2000). 
The implications of the findings in this study are 
far-reaching. From previous reports (Gassner et 
al., 2005; Wagner et al., 2005), it can be inferred 
that units of blood from the two weak D positive 
donors observed pose the potential risk of allo-
immunizing Rh-negative recipients. If the two 
samples were from individuals of Rh-negative 
mothers having no preformed anti-D, by the 
procedures of some laboratories they would be 
typed as Rh-negative by direct agglutination test. 
Rh immune prophylaxis would not be given to 
the mother, possibly resulting in her being anti-
gen D-alloimmunized. Therefore the universal 
acceptance of weak D typing of individual who 
type as Rh-negative with direct agglutination 
technique is justified by the results of this study. 
Neglect of such a procedure may result in unnec-
essary incidence of preventable haemolytic dis-
ease of the newborn with its severe clinical im-
plications. 
Sometimes when an Rh-negative woman be-
comes pregnant it becomes necessary to deter-
mine the partner’s Rh status to assist in the 
proper management of the woman if there is the 
possibility of the baby being Rh-positive. By 
using only direct agglutination, if the partner’s 
weak D red cells are not detected, the result will 
be similar to earlier instances mentioned above. 
Because of the rarity of Rh-negative donors, 
carefully selected patients may be tested for 
weak D when typed as Rh-negative by direct 
agglutination. That may be considered when no 
Rh-negative blood is available.  In that case it 
should be borne in mind that current knowledge 
indicates that majority of individuals with a 
weak D phenotype can safely receive Rh-
positive blood and do not make anti-D 
(Westhoff, 2004). If the two subjects who typed 
as weak D positive required blood transfusion, 
they could therefore receive Rh-positive blood in 
the absence of Rh-negative blood unit. The ques-
tion that comes to mind is, what, if the weak D 
reaction is due to a partial D? In our African 
setting it may not be a problem. Only about 5-
10% of the weak Ds are partial Ds, most of 
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Fig 1. Characteristics of the Rhesus D among donors. A is the frequency of Rh –ve and Rh +ve 
among the whole donor populations; B is the frequency of Rh –ve and Rh +ve among the female 
donors; C is the frequency of Rh –ve and Rh +ve among the male donors and D is the frequency 
of the apparently negative subjects who reacted positive and negative to the weak D test. 
  Rh-negative Rh-positive Total 
Frequency Percentage Frequency Percentage Frequency Percentage 
Male 25 6.25 240 60.00 265 66.25 
Female 6 1.50 129 32.25 135 33.75 
Total 31 7.75 369 92.25 400 100 
Table 1: Prevalence of Rh-negative among males and females 
  Rh-negative Weak D-positive Weak D-negative 
Frequency Percentage Frequency Percentage Frequency Percentage 
Male 25 80.65 2 6.45 23 74.19 
Female 6 19.35 - - 6 19.35 
Total 31 100 2 6.45 29 93.55 
Table 2: Prevalence of weak D phenotype among Rh-negative males and females 
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which are DVI Rh variant (Shulman, 2002; Shul-
man, 2005). The DVI is more frequent among 
Caucasians but not Africans. Because RhIg is 
not completely without risk (HCV and unknown 
variant Creutzfeldt-Jakob disease), is costly, and 
is derived from human source material that is in 
short supply, it is prudent policy to avoid its 
unnecessary use (Shulman, 2005). 
 
CONCLUSION 
This study has found that 6.45% of blood donors 
who were typed as Rhesus negative are actually 
weak D positive. Because of the potential risk of 
alloimmunization caused by such red cells, indi-
rect antiglobulin testing must constitute part of 
the routine typing of all blood donors. It would 
therefore, be prudent for policy makers and 
transfusion units to carefully consider the issue 
of the incidence of the weak D and come up with 
policies for its testing. Also, the universal accep-
tance of weak D testing of newborns is valid and 
need to be implemented. Finally, donors and 
husbands of Rh negative women who type as Rh
-negative may need to be typed for weak D, even 
when monoclonal anti-D is used. 
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